- Home
- PAM vs ACLX Comparison
PAM vs ACLX Comparison
Compare PAM & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAM
- ACLX
- Stock Information
- Founded
- PAM 1945
- ACLX 2015
- Country
- PAM Argentina
- ACLX United States
- Employees
- PAM N/A
- ACLX N/A
- Industry
- PAM Electric Utilities: Central
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- PAM Utilities
- ACLX Health Care
- Exchange
- PAM Nasdaq
- ACLX Nasdaq
- Market Cap
- PAM 4.5B
- ACLX 4.4B
- IPO Year
- PAM N/A
- ACLX 2022
- Fundamental
- Price
- PAM $87.29
- ACLX $86.52
- Analyst Decision
- PAM Hold
- ACLX Strong Buy
- Analyst Count
- PAM 2
- ACLX 9
- Target Price
- PAM $92.75
- ACLX $117.78
- AVG Volume (30 Days)
- PAM 517.3K
- ACLX 388.2K
- Earning Date
- PAM 11-04-2025
- ACLX 11-05-2025
- Dividend Yield
- PAM N/A
- ACLX N/A
- EPS Growth
- PAM N/A
- ACLX N/A
- EPS
- PAM 0.24
- ACLX N/A
- Revenue
- PAM $1,926,000,000.00
- ACLX $35,898,000.00
- Revenue This Year
- PAM $136,919.08
- ACLX N/A
- Revenue Next Year
- PAM $36.38
- ACLX $220.95
- P/E Ratio
- PAM $15.16
- ACLX N/A
- Revenue Growth
- PAM N/A
- ACLX N/A
- 52 Week Low
- PAM $54.95
- ACLX $47.86
- 52 Week High
- PAM $97.55
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- PAM 71.50
- ACLX 52.70
- Support Level
- PAM $82.74
- ACLX $84.50
- Resistance Level
- PAM $90.00
- ACLX $90.30
- Average True Range (ATR)
- PAM 4.42
- ACLX 3.62
- MACD
- PAM 1.32
- ACLX -0.37
- Stochastic Oscillator
- PAM 88.25
- ACLX 42.47
About PAM Pampa Energia S.A.
Pampa Energia SA and its subsidiaries are engaged in the Energy business, mainly in oil and gas production and power generation. The firm's operating business segments are Oil and Gas, Generation, Petrochemicals, Holding, Transportation, and Others. The company derives the maximum revenue from the oil and gas segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.